Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 26, 2022; 10(27): 9670-9679
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9670
Clinical characteristics and prognosis of orbital solitary fibrous tumor in patients from a Chinese tertiary eye hospital
Ming-Yu Ren, Jing Li, Yi-Xiang Wu, Rui-Miao Li, Chi Zhang, Li-Min Liu, Jing-Jing Wang, Yu Gao
Ming-Yu Ren, Yi-Xiang Wu, Rui-Miao Li, Li-Min Liu, Jing-Jing Wang, Yu Gao, Department of Orbital Disease and Ocular Tumor, Hebei Eye Hospital, Xingtai 054001, Hebei Province, China
Jing Li, Intensive Care Unit, Xingtai Third Hospital, Xingtai 054001, Hebei Province, China
Chi Zhang, Department of Medical Imaging, Hebei Eye Hospital, Xingtai 054001, Hebei Province, China
Author contributions: Ren MY and Li J performed the research and wrote the paper; Ren MY and Li RM designed the research and supervised the report; Ren MY and Liu LM designed the research and contributed to the analysis; Wang JJ, Zhang C, and Gao Y provided clinical advice; Ren MY and Li J supervised the report; all authors revised the paper and approved the final version for submission.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Hebei Eye Hospital.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All authors have no financial relationships to disclose.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at Participants gave informed consent for data sharing.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Ming-Yu Ren, MMed, Associate Chief Physician, Department of Orbital Disease and Ocular Tumor, Hebei Eye Hospital, No. 399 Quanbeidong, Xingtai 054001, Hebei Province, China.
Received: May 27, 2022
Peer-review started: May 27, 2022
First decision: June 27, 2022
Revised: July 5, 2022
Accepted: August 21, 2022
Article in press: August 21, 2022
Published online: September 26, 2022
Core Tip

Core Tip: The clinical manifestations of orbital solitary fibrous tumor (SFT) are diverse and not specific. In most cases, the lesions occur outside the muscular cone, are localized at the superomedial quadrant and inferomedial quadrant of the orbit. The mean computed tomography values of lesions are variable, and the signal of lesions on magnetic resonance imaging is uncertain. Contrast-enhanced imaging showed that most part of the lesions was significantly enhanced, whereas there were patchy slightly enhanced areas in them. Delineating SFT from histologic mimics requires nuclear staining for STAT6 as a diagnostic adjunct in conjunction with CD34 positivity. Ki-67 labelling index may be extremely low, and malignant forms with an enhanced propensity for local recurrence have been reported.